22
May
2009
Posted in I - Series C, Q - 2Q09, R - WEST, X - Device (Cardiology), XX - CA
Sadra Medical (Campbell, CA) a clinical-stage device company focused on minimally invasive percutaneous aortic valve replacement, closed a $30M Series C financing. Participants include Accuitive Medical Ventures, Boston Scientific, Finistere Ventures, Firstmark Capital, Oakwood, Onset Ventures and SV Life Sciences.